Genmab — Maj 2021
-
-
Now we have to call it Rybrevant. Have just got used Amivantamab!
-
by FDA, think nobody was expecting this so early lol
https://www.fda.gov/news-events/press-announcements/fda-approves-first-targeted-therapy-subset-non-small-cell-lung-cancer -
-
Det er set før på nyheder.
-
Genmab Announces that Janssen has been Granted U.S. FDA Approval for RYBREVANT
(amivantamab-vmjw) for Patients with Metastatic Non-small Cell Lung Cancer https://ir.genmab.com/news-releases/news-release-details/genmab-announces-janssen-has-been-granted-us-fda-approval-0 -
Det er rimeligt vildt med godkendelse allerede nu.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind